Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MIPS is a world-leading medical technology company specializing in helmet-based safety and brain protection. Based on over 25 years of research from the Royal Institute of Technology and the Karolinska Institute, the company developed the Multi-directional Impact Protection System (MIPS), which uses a low-friction layer to reduce rotational motion transferred to the brain during angled impacts. MIPS operates as an ingredient brand, licensing its patented technology to global helmet manufacturers across the bike, snow, moto, and safety markets. The company is publicly traded on the Nasdaq Stockholm and is recognized for its rigorous scientific testing and commitment to reducing the risk of traumatic brain injuries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MIPS CRF.